Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: TechSci Research | PRODUCT CODE: 1738273

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1738273

Next Generation Sequencing Informatics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Products & Services, By Application, By End User, By Region & Competition, 2020-2030F

PUBLISHED:
PAGES: 185 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Description

Table of Contents

The Global Next Generation Sequencing (NGS) Informatics Market was valued at USD 5.48 billion in 2024 and is projected to reach USD 18.74 billion by 2030, growing at a CAGR of 22.74%. The market is witnessing substantial growth due to the increasing incidence of cancer and expanding clinical applications of NGS. In 2020, the Global Cancer Observatory recorded over 19 million new cancer cases, with breast, lung, colorectal, prostate, and stomach cancers being the most common. Contributing to market expansion are the rising number of DNA sequencing samples, declining sequencing costs, government-backed genomic initiatives, and growing adoption of NGS over traditional microarray technologies. As sequencing becomes more affordable and integral to disease diagnosis and treatment, the demand for robust informatics platforms capable of managing, analyzing, and interpreting large-scale genomic data continues to grow.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.48 Billion
Market Size 2030USD 18.74 Billion
CAGR 2025-203022.74%
Fastest Growing SegmentData Interpretation
Largest MarketNorth America

Key Market Drivers

Rising Adoption of Precision Medicine and Genomic-Based Diagnostics

The widespread integration of precision medicine and genomic diagnostics into clinical workflows is a key driver of the NGS informatics market. By enabling the analysis of entire genetic profiles, NGS facilitates identification of disease-causing mutations and supports individualized treatment strategies. Government-led initiatives such as the NIH's "All of Us Research Program" reflect this trend, collecting genetic data from over one million participants-over 600,000 of whom had enrolled by 2023. This surge in data fuels the demand for informatics platforms that can store, process, and interpret high-throughput sequencing information. Additionally, broader insurance coverage for genomic testing in countries like the United States is encouraging greater adoption of NGS technologies in hospitals and clinical labs. According to CMS, spending on NGS-based tests has significantly increased, underlining the growing clinical importance of these tools. As a result, demand for scalable NGS informatics systems that can automate variant analysis and support clinical decisions using AI and ML is accelerating across healthcare systems.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in NGS Informatics

The integration of AI and ML into NGS informatics is revolutionizing genomic data analysis by enabling rapid, accurate, and efficient interpretation of complex datasets. These technologies are embedded into pipelines for variant calling, annotation, and clinical reporting, helping to identify structural rearrangements and polygenic risk scores. Tools like DeepVariant and AlphaFold have improved the interpretation of genomic data in oncology and rare disease diagnostics. Government backing, such as the U.S. National Artificial Intelligence Initiative and the EU's Horizon Europe program, underscores global efforts to integrate AI in biomedical research. AI models also enhance the utility of genomic data when integrated with electronic health records, enabling personalized, evidence-based treatment recommendations. As these models become increasingly sophisticated and validated, they are expected to become central to commercial NGS informatics solutions, supporting the broader implementation of precision medicine.

Key Market Players

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • SOPHiA GENETICS SA
  • Precigen, Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Eagle Genomics Limited
  • BGI Genomics Co., Ltd.

Report Scope:

In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Product & Services:

  • Storage and Computing Tools
  • Commercial Data Analysis
  • Data Interpretation and Reporting Tools
  • Next Generation Sequencing (NGS) Informatics Services
  • Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

  • Drug Discovery
  • Genetic Screening
  • Disease Diagnosis
  • Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations:

Global Next Generation Sequencing (NGS) Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Show more
Product Code: 15017

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
    • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
    • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
    • 5.2.5. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Products & Services
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Country
    • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Global Next Generation Sequencing (NGS) Informatics Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. F. Hoffmann-La Roche Ltd.
  • 15.3. PerkinElmer, Inc.
  • 15.4. SOPHiA GENETICS SA
  • 15.5. Precigen, Inc.
  • 15.6. QIAGEN N.V.
  • 15.7. Illumina, Inc.
  • 15.8. Agilent Technologies, Inc.
  • 15.9. Eagle Genomics Limited
  • 15.10. BGI Genomics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!